Geng Sheng Yang
Direttore/Membro del Consiglio presso XinYu Pharmaceutical Co., Ltd.
Profilo
Geng Sheng Yang is an Independent Director at XinYu Pharmaceutical Co., Ltd.
since 2015.
He completed his undergraduate degree from Zhejiang University of Technology in 1985.
Posizioni attive di Geng Sheng Yang
| Società | Posizione | Inizio |
|---|---|---|
XinYu Pharmaceutical Co., Ltd.
 XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Direttore/Membro del Consiglio | 01/09/2015 |
Formazione di Geng Sheng Yang
| Zhejiang University of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
XinYu Pharmaceutical Co., Ltd.
XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Borsa valori
- Insiders
- Geng Sheng Yang
